IRENE SHULGA: Open Payments
NPI 1528164480 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 17 payments from 4 companies in 2025. Trend: 2023 $137 · 2024 $321 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
Products named: COBENFY, INGREZZA, HETLIOZ, ERZOFRI EXTENDED-RELEASE.
Industry payments across NY — which companies pay providers there.
